Key facts
- Sunrise (Diagnostic Equipment)’s last known valuation is $101.0M (Jul 2025).
- It has raised $59.5M; the latest was Later Stage VC ($29.2M) in Jul 2025.
- Notable investors include General Catalyst, European Innovation Council, Khosla Ventures, UI Investissement, Noshaq — 24 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 24 names
- ·Watchlist + deal alerts for Sunrise (Diagnostic Equipment)
- ·The full record, as it builds
Funding rounds
No funding rounds for Sunrise (Diagnostic Equipment) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Sunrise (Diagnostic Equipment)
Developer of a wireless sleep monitoring device designed for the detection and assessment of sleep apnea and related disorders. The company offers a certified, comprehensive sleep test that tracks snoring, nocturnal awakenings, insomnia, and fatigue through a simple at-home process, enabling individuals to obtain accurate diagnostic information and access appropriate treatment options without the need for complex clinical setups.
- Sector
- Healthcare
- HQ
- Namur, Belgium
- Founded
- 2015
- Employees
- 147
- Website
- row.hellosunrise.com/
- Ownership
- Privately Held (backing)
Sunrise (Diagnostic Equipment) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Sunrise (Diagnostic Equipment) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Sunrise (Diagnostic Equipment) in its N-PORT filings yet. We sweep new filings monthly.